Dr Susan Lalondrelle : Clinical oncology

Home
Dr Susan Lalondrelle

Bupa Platinum consultant
Fee assured
Verified account
Open Referral network

Overview

Offers

Face-to-face consultations
Video and telephone consultations
Home chemotherapy

About me

I am a clinical oncologist specialising in the treatment of gynaecological and skin cancers. I deliver radiotherapy, chemotherapy, immunotherapy, targeted therapies and brachytherapy as treatments for these cancers.

Areas of interest

Radiotherapy: online adaptive radiotherapy, MRlinac/ MRguided radiotherapy, superficial radiotherapy, image guided RT, VMAT

Brachytherapy: intracavitary and interstitial brachytherapy, contact / mold brachytherapy

Systemic therapies: chemotherapy, immunotherapy, targeted therapies

Medical secretaries

Tammy Taylor
Royal Marsden Hospital Downs Road SUTTON SM2 5PT
020 8661 3272
tammy.taylor@rmh.nhs.uk

About me

External resources

Royal Marsden Website

Current NHS consultant posts held

Consultant Clinical Oncologist, Royal Marsden NHS Foundation Trust, London, UK

Research interests

Actively involved in clinical research with particular interests in radiotherapy technologies : MRlinac, online adaptive radiotherapy, stereotactic radiotherapy, intensity modulated, image guided radiotherapy and adaptive planning to improve accuracy and reduce toxicity. I am also involved in image guided brachytherapy, the assessment of functional imaging for radiotherapy planning and the combination of biological agents with radiotherapy.
I am a chief investigator for clinical trials of adaptive radiotherapy and ctDNA in cervix cancer as well international studies of systemic therapies.

Awards received

2012 Royal College of Radiologists RCR-KAY Travel Fellowship
2008 Royal College of Radiologists Small Projects Grant
2008 Sylvia Lawler Prize, Royal Society of Medicine
2007 ECCO-AACR-ASCO Fellowship
2006 Royal Marsden and Institute of Cancer Research General Clinical Research Fund Grant

(Additional) Languages spoken

Publications

Outcomes of pelvic and para-aortic stereotactic reirradiation for gynaecological cancer recurrence. Clin Transl Radiat Oncol. 2025

Real World Multi-centre UK Review of Nivolumab Monotherapy in Metastatic Endometrial Cancer With Mismatch Repair Deficiency During COVID-19
Clin Oncol (R Coll Radiol). 2025.

Survival disparities in women with endometrial cancer based on metastasis size in the sentinel lymph node: A tertiary cancer centre observational cohort study
Gynecol Reprod Biol. 2025 Aug

Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in participants with high-risk locally advanced cervical cancer.
Gynecol Oncol. 2025

Quantitative and automatic plan-of-the-day assessment to facilitate adaptive radiotherapy in cervical cancer.
Phys Med Biol. 2025

Implementing Plan of the Day for Cervical Cancer: A Comparison of Target Volume Generation Methods.
Adv Radiat Oncol. 2024

Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance-Guided Radiotherapy.
JAMA Netw Open. 2024

Predicting cervical cancer target motion using a multivariate regression model to enable patient selection for adaptive external beam radiotherapy.
Phys Imaging Radiat Oncol. 2024

T-cell receptor determinants of response to chemoradiation in locally-advanced HPV16-driven malignancies.
Front Oncol. 2024

Circulating HPV DNA as a Biomarker for Pre-Invasive and Early Invasive Cervical Cancer: A Feasibility Study.
Cancers (Basel). 2023

Predicting Response to Radical Chemoradiotherapy with Circulating HPV DNA (cHPV-DNA) in Locally Advanced Uterine Cervix Cancer.
Cancers (Basel). 2023

Re-irradiation: From Cell Lines to Patients, Filling the (Science) Gap in the Market.
Clin Oncol (R Coll Radiol). 2023

Carpe Diem: Making the Most of Plan-of-the-Day for Cervical Cancer Radiation Therapy.
Pract Radiat Oncol. 2023

My qualifications & training

Qualifications

Certificate of Completion of Specialist Training London Deanery 2011
Fellowship Royal College of Radiologists 2006
Membership Royal college of Physicians 2002
BM BSc University of Southampton 1998
MD(Res) University Of London 2013

GMC registration

Reference number 4470919

Details of entry to specialist register

Clinical oncology , 2011

Affiliations / memberships

RCR
RCP
ESTRO
ESGO
ASTRO

My private practice

Practice hours

Practice
Day
Hours
Appt Bookings

The Royal Marsden Hospital, SM2 5PT
Friday
09:00 - 12:00
020 8661 3272

The Royal Marsden Hospital, SW3 6JJ
Tuesday
15:30 - 18:30
020 8661 3272

Post treatment communication

Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)

The Royal Marsden Hospital (5-50) The Royal Marsden Hospital (5-50)
A1080
Stereotactic radiotherapy (SRT), second to fifth sessions, including adjustments, using Cyberknife or similar SRT technology - (1-5)

The Royal Marsden Hospital (1-5)
X0005
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-56 days - (1-5)

The Royal Marsden Hospital (1-5)
X6760
Preparation for superficial radiotherapy with imaging, dosimetry and calculation - (1-5)

The Royal Marsden Hospital (1-5)
X0007
Clinical supervision of external beam radiotherapy, up to and including 15 fractions or part thereof - (1-5)

The Royal Marsden Hospital (1-5)
A1070
Stereotactic radiotherapy (SRT), first/sole session using Cyberknife or similar SRT technology - (1-5)

The Royal Marsden Hospital (1-5)
A0380
Stereotactic radiotherapy (SRT) using GammaKnife or similar SRT technology - (1-5)

The Royal Marsden Hospital (1-5)
Show All (7 )...

Report this page Print page

Finder

Note: